• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与子宫内膜样子宫内膜癌淋巴结转移相关的生物标志物

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma.

作者信息

Mairé Mathilde, Bourdon Aurélien, Soubeyran Isabelle, Lucchesi Carlo, Guyon Frédéric, Babin Guillaume, Floquet Anne, Petit Adeline, Baud Jessica, Velasco Valérie, Querleu Denis, Croce Sabrina

机构信息

Department of Surgery, Institut Bergonie, 33076 Bordeaux, France.

Department of Bioinformatics, Institut Bergonie, 33076 Bordeaux, France.

出版信息

Cancers (Basel). 2022 Apr 27;14(9):2188. doi: 10.3390/cancers14092188.

DOI:10.3390/cancers14092188
PMID:35565317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9099548/
Abstract

INTRODUCTION

Lymph node metastasis is determinant in the prognosis and treatment of endometrioid endometrial cancer (EEC) but the risk-benefit balance of surgical lymph node staging remains controversial.

OBJECTIVE

Describe the pathways associated with lymph node metastases in EEC detected by whole RNA sequencing.

METHODS

RNA-sequencing was performed on a retrospective series of 30 non-metastatic EEC. N+ and N- patients were matched for tumoral size, tumoral grade and myometrial invasion.

RESULTS

Twenty-eight EECs were analyzable (16 N+ and 12 N-). Bioinformatics Unsupervised analysis revealed three patterns of expression, enriched in N+, mix of N+/N- and enriched in N-, respectively. The cluster with only N+ patient overexpressed extra cellular matrix, epithelial to mesenchymal and smooth muscle contraction pathways with respect to the N- profile. Differential expression analysis between N+ and N- was used to generate a 54-genes signature with an 87% accuracy.

CONCLUSION

RNA-expression analysis provides a basis to develop a gene expression-based signature that could pre-operatively predict lymph node invasion.

摘要

引言

淋巴结转移是子宫内膜样腺癌(EEC)预后和治疗的决定性因素,但手术淋巴结分期的风险效益平衡仍存在争议。

目的

描述通过全RNA测序检测到的EEC中与淋巴结转移相关的途径。

方法

对30例非转移性EEC的回顾性系列进行RNA测序。N+和N-患者在肿瘤大小、肿瘤分级和肌层浸润方面进行匹配。

结果

28例EEC可分析(16例N+和12例N-)。生物信息学无监督分析揭示了三种表达模式,分别在N+中富集、N+/N-混合和N-中富集。仅N+患者的聚类相对于N-谱过度表达细胞外基质、上皮-间质转化和平滑肌收缩途径。N+和N-之间的差异表达分析用于生成一个准确率为87%的54基因特征。

结论

RNA表达分析为开发基于基因表达的特征提供了基础,该特征可在术前预测淋巴结侵犯。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/97b0d8001f7f/cancers-14-02188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/592ef10fd6bf/cancers-14-02188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/b4a7b4c6ef0e/cancers-14-02188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/97b0d8001f7f/cancers-14-02188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/592ef10fd6bf/cancers-14-02188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/b4a7b4c6ef0e/cancers-14-02188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/9099548/97b0d8001f7f/cancers-14-02188-g003.jpg

相似文献

1
Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma.与子宫内膜样子宫内膜癌淋巴结转移相关的生物标志物
Cancers (Basel). 2022 Apr 27;14(9):2188. doi: 10.3390/cancers14092188.
2
Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.建立用于预测早期子宫内膜癌患者淋巴结转移的新型五基因生物标志物组的初步研究。
Front Oncol. 2020 Jan 21;9:1508. doi: 10.3389/fonc.2019.01508. eCollection 2019.
3
Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.具有微囊状、长形和碎片状(MELF)型肌浸润的子宫内膜样腺癌:免疫组织化学在检测隐匿性淋巴结转移中的作用及其临床意义。
Hum Pathol. 2017 Dec;70:6-13. doi: 10.1016/j.humpath.2017.05.026. Epub 2017 Jun 7.
4
Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.FIGO 临床分期 I 期、I 级子宫内膜样癌中与隐匿性淋巴结转移相关的组织学特征。
Histopathology. 2014 Feb;64(3):389-98. doi: 10.1111/his.12254. Epub 2013 Nov 12.
5
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.根据国际妇产科联盟(FIGO)分期,子宫内膜样组织学类型的子宫内膜腺癌患者经充分手术分期后盆腔淋巴结转移的发生率。
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):269-73. doi: 10.1111/j.1525-1438.2007.00996.x.
6
Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.微囊状、细长状及破碎状浸润主要与国际妇产科联盟I级子宫内膜样子宫内膜癌中的孤立肿瘤细胞模式转移相关。
Hum Pathol. 2017 Apr;62:33-39. doi: 10.1016/j.humpath.2016.10.023. Epub 2016 Nov 15.
7
Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?中危ⅠA 期、分级 1/2、肿瘤直径大于 2cm 的子宫内膜样型子宫内膜癌患者是否需要进行淋巴结清扫术?
BMC Cancer. 2017 Oct 23;17(1):696. doi: 10.1186/s12885-017-3671-0.
8
Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.预测子宫内膜样子宫内膜癌患者淋巴结转移风险的列线图
Int J Gynecol Pathol. 2016 Sep;35(5):395-401. doi: 10.1097/PGP.0000000000000246.
9
Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study.基于超声的子宫内膜癌女性术前淋巴结转移风险预测模型:模型建立研究。
Ultrasound Obstet Gynecol. 2020 Sep;56(3):443-452. doi: 10.1002/uog.21950.
10
FOXA1 is associated with high tumor grade, myometrial invasion and lymph node invasion in endometrial endometrioid carcinoma.FOXA1 与子宫内膜样腺癌的高肿瘤分级、肌层浸润和淋巴结浸润相关。
Ginekol Pol. 2021;92(8):544-549. doi: 10.5603/GP.a2021.0016. Epub 2021 Apr 12.

引用本文的文献

1
Identifying Cancer Stage-Related Biomarkers for Lung Adenocarcinoma by Integrating Both Node and Edge Features.通过整合节点和边特征来识别肺腺癌的癌症分期相关生物标志物。
Genes (Basel). 2025 Feb 24;16(3):261. doi: 10.3390/genes16030261.
2
The impact of integrated genomic analysis on molecular classifications and prognostic risk stratification in endometrial cancer: a Chinese experience.综合基因组分析对子宫内膜癌分子分类及预后风险分层的影响:一项中国经验
Front Oncol. 2025 Feb 6;15:1541562. doi: 10.3389/fonc.2025.1541562. eCollection 2025.
3
Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.

本文引用的文献

1
Sentinel lymph node biopsy in endometrial cancer: state of the art.子宫内膜癌前哨淋巴结活检:现状
Transl Cancer Res. 2020 Dec;9(12):7725-7733. doi: 10.21037/tcr.2020.04.21.
2
Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.宫颈癌患者前哨淋巴结活检术后下肢淋巴水肿
Cancers (Basel). 2021 May 13;13(10):2360. doi: 10.3390/cancers13102360.
3
A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.一种基于新型转录因子的子宫内膜癌预后标志物:建立与验证
预测子宫内膜癌淋巴结转移的模型:系统评价和文献计量分析。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241248398. doi: 10.1177/17455057241248398.
4
Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer.利用临床变量预测子宫内膜癌的淋巴结转移。
Jpn J Clin Oncol. 2024 Jan 7;54(1):38-46. doi: 10.1093/jjco/hyad135.
5
Metabolic risk score as a predictor in a nomogram for assessing myometrial invasion for endometrial cancer.代谢风险评分作为预测子宫内膜癌肌层浸润的列线图中的一个预测指标。
Oncol Lett. 2023 Feb 6;25(3):114. doi: 10.3892/ol.2023.13700. eCollection 2023 Mar.
Onco Targets Ther. 2021 Apr 13;14:2579-2598. doi: 10.2147/OTT.S293085. eCollection 2021.
4
Surgical complications occurring during minimally invasive sentinel lymph node detection in endometrial cancer patients. A systematic review of the literature and metanalysis.在子宫内膜癌患者微创前哨淋巴结检测过程中发生的手术并发症。文献系统评价和荟萃分析。
Eur J Surg Oncol. 2021 Aug;47(8):2142-2149. doi: 10.1016/j.ejso.2021.03.253. Epub 2021 Mar 30.
5
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
6
Molecular characterization in the prediction of disease extent in endometrial carcinoma.在子宫内膜癌中预测疾病程度的分子特征分析。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:478-483. doi: 10.1016/j.ejogrb.2020.10.031. Epub 2020 Oct 16.
7
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer.成纤维细胞激活蛋白(FAP)高表达预示高级别浆液性卵巢癌预后不良。
BMC Cancer. 2020 Oct 27;20(1):1032. doi: 10.1186/s12885-020-07541-6.
8
MSX1-A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas.MSX1 作为一种有潜力的标志物,有助于保留子宫的子宫内膜癌疗法。
Int J Mol Sci. 2020 Jun 25;21(12):4529. doi: 10.3390/ijms21124529.
9
Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.肿瘤微环境中免疫景观对子宫内膜癌预后的意义。
J Cell Mol Med. 2020 Jul;24(14):7767-7777. doi: 10.1111/jcmm.15408. Epub 2020 May 19.
10
Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.计算分析鉴定参与子宫内膜癌进展的细胞外基质分子。
PLoS One. 2020 Apr 21;15(4):e0231594. doi: 10.1371/journal.pone.0231594. eCollection 2020.